deafness-vitiligo-achalasia syndrome

MeSH: C565642ORPHA: 3239

Overview

Deafness-vitiligo-achalasia syndrome is characterized by the association of deafness, short stature, vitiligo, muscle wasting, and achalasia

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with deafness-vitiligo-achalasia syndrome, sourced from HPO and Orphanet clinical annotations.

Sensorineural hearing impairmentHypopigmented skin patchesEEG abnormalityAchalasiaSkeletal muscle atrophySevere short stature

Classification & Codes

MeSH Code

C565642

Orphanet Code

ORPHA:3239
deafness-vitiligo-achalasia syndrome
MeSHC565642
OrphanetORPHA:3239
Treatments0 drug(s)
Symptoms on record6 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO